tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Debanjana Chatterjee, 20 are a BUY (90.91%), 2 are a HOLD (9.09%).
Analyst Debanjana Chatterjee, currently employed at JONESTRADING, carries an average stock price target met ratio of 33.33% that have a potential upside of 48.83% achieved within 67 days.
Debanjana Chatterjee’s has documented 42 price targets and ratings displayed on 9 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on CTNM, Contineum Therapeutics, Common Stock at 15-Sep-2026.
Analyst best performing recommendations are on ABCL (ABCELLERA BIOLOGICS ).
The best stock recommendation documented was for ABCL (ABCELLERA BIOLOGICS ) at 4/10/2026. The price target of $11 was fulfilled within 126 days with a profit of $7.46 (210.73%) receiving and performance score of 16.72.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 22-Jan-2025
$11
$1.26 (12.94%)
$11
Buy Since 28-May-2026
$16
$6.26 (64.27%)
$13
20 days ago
(08-Sep-2026)
1/4 (25%)
$7.09 (79.57%)
27
Buy Since 08-May-2026
$17
$7.26 (74.54%)
$11
2 months 26 days ago
(02-Jul-2026)
1/2 (50%)
$5.38 (46.30%)
52
Buy Since 16-May-2023
$16
$6.26 (64.27%)
3 months 3 days ago
(25-Jun-2026)
12/13 (92.31%)
$5.79 (56.71%)
453
Buy Since 02-Oct-2024
$15
$5.26 (54.00%)
$10
3 months 13 days ago
(15-Jun-2026)
3/4 (75%)
$7.73 (106.33%)
553
Which stock is Debanjana Chatterjee most bullish on?
Which stock is Debanjana Chatterjee most reserved on?
What Year was the first public recommendation made by Debanjana Chatterjee?
